Previous 10 | Next 10 |
home / stock / medif / medif news
MediPharm Labs ([[MEDIF]] +0.6%) subsidiary, MediPharm Labs Inc., has initiated a clinical trial to research and evaluate the effectiveness of MediPharm Labs’ proprietary cannabis-derived medical products and formulations on the treatment of end-stage renal disease or Chronic Kidney Di...
Clinical trial will evaluate the effectiveness of MediPharm Labs proprietary GMP cannabis-derived formulations and medical products and expand MediPharm Labs owned IP In the United States, 37 million or more than 1 in 7 adults, are estimated to have chronic kidney disease (CKD) an...
It’s time for your Daily Hit of cannabis financial news for October 5, 2020. On the Site Michigan In December of 2019, Michigan became the tenth state in the U.S. to legalize adult-use cannabis. Less than a year in, it’s already outpaced Nevada to become ...
FinancialBuzz.com News Commentary New York, NY (10/5/2020) – Presently, the medical cannabis sector accounts for the majority of the market share, and progress is slowly being made in removing the stigmas associated with such products. For example, the U.S. Food and Drug Administ...
European Consumer Healthcare and Generics companies STADA entered into supply agreement with a wholly owned subsidiary of MediPharm Labs (MEDIF) to provide medical cannabis products for the European pharma sector.Under the terms of the partnership, MediPharm will supply GMP cer...
A milestone for the global cannabis industry as STADA, in partnership with MediPharm, forges the way as a large pharmaceutical company commercializing medical cannabis products Partnership validates MediPharm Labs’ GMP pharmaceutical-quality cannabis production and, combine...
Last week was a tough week for cannabis stocks as ETFs plummeted with disappointing earnings reports. The ETFMG Alternative Harvest ETF (NYSE: MJ), the AdvisorShares Pure Cannabis ETF (NYSE: YOLO), The Cannabis ETF (NYSE: THCX), the Amplify Seymour Cannabis ETF (NYSE: CNBS) all lost a...
MediPharm Labs ([[MEDIF]] +1.2%) to acquire remaining 20% ownership interest in the Company’s 80%-owned subsidiary MediPharm Labs Australia, a global pharmaceutical-quality supply chain that is qualified to serve new emerging medical markets internationally.The company will p...
TORONTO, Sept. 28, 2020 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE:MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivati...
MediPharm Labs (MEDIF) entered into a new white-label supply agreement with DanCann Pharma; marking its third supply agreement for the export of finished products to Denmark expanding its revenue opportunity in an emerging medicinal cannabis market.DanCann Pharma is a medical cannab...
News, Short Squeeze, Breakout and More Instantly...
MediPharm Labs Announces Voting Results From the 2024 Annual Meeting of Shareholders Canada NewsWire TORONTO , June 26, 2024 /CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company"), a pharmaceutical comp...
MediPharm Labs Acquires Advanced Medical Cannabis Delivery Method Technology from Remidose Aerosols Canada NewsWire MediPharm has licenced global manufacturing, distribution, and sales rights of the novel advanced medical cannabis technology from Remidose Aerosols. Product...